C. Lam

发表

A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea

I. Hall, K. Garsed, J. Chernova, 2013, Gut.

Distinct Abnormalities of Small Bowel and Regional Colonic Volumes in Subtypes of Irritable Bowel Syndrome Revealed by MRI

C. Lam, R. Spiller, E. Cox, 2016, The American Journal of Gastroenterology.

Effects of bowel cleansing on the intestinal microbiota

Jarkko Salojärvi, Anne Salonen, Luca Marciani, 2014, Gut.

Increased fasting small-bowel water content in untreated coeliac disease and scleroderma as assessed by magnetic resonance imaging

K. Garsed, C. Lam, L. Marciani, 2019, United European gastroenterology journal.

Corticotrophin releasing factor increases ascending colon volume after a fructose test meal in healthy humans : a randomised control trial

C. Lam, L. Marciani, R. Spiller, 2017 .

Corticotropin-releasing factor increases ascending colon volume after a fructose test meal in healthy humans: a randomized controlled trial.

C. Lam, L. Marciani, R. Spiller, 2016, The American journal of clinical nutrition.

Differential Effects of FODMAPs (Fermentable Oligo-, Di-, Mono-Saccharides and Polyols) on Small and Large Intestinal Contents in Healthy Subjects Shown by MRI

C. Lam, L. Marciani, R. Spiller, 2013, The American Journal of Gastroenterology.

Stimulation of colonic motility by oral PEG electrolyte bowel preparation assessed by MRI: comparison of split vs single dose

K. Garsed, C. Lam, L. Marciani, 2014, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Practical Approach to Clinical Assessment of Irritable Bowel Syndrome

C. Lam, R. Spiller, 2013 .

Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): a multicentre, parallel-group, randomised placebo-controlled trial

M. Hastings, C. Lam, P. Whorwell, 2015 .

An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome

C. Lam, R. Spiller, 2012, Journal of neurogastroenterology and motility.

Novel MRI tests of orocecal transit time and whole gut transit time: studies in normal subjects

C. Lam, L. Marciani, R. Spiller, 2013, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea: origin and effect of gut transit

K. Garsed, M. Hastings, C. Lam, 2013, Gut.

A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D)

M. Hastings, C. Lam, P. Whorwell, 2015, Gut.

Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): study protocol for a randomised controlled trial

C. Lam, R. Spiller, S. Mehta, 2013, Trials.

The shifting interface between IBS and IBD.

C. Lam, R. Spiller, 2011, Current opinion in pharmacology.

Colonic Gene Expression and Fecal Microbiota in Diarrhea-predominant Irritable Bowel Syndrome: Increased Toll-like Receptor 4 but Minimal Inflammation and no Response to Mesalazine

C. Lam, R. Spiller, A. Hartikainen, 2021, Journal of neurogastroenterology and motility.

Colonic response to laxative ingestion as assessed by MRI differs in constipated irritable bowel syndrome compared to functional constipation

C. Lam, K. Garsed, C. Lam, 2016, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Pain Severity Correlates With Biopsy-Mediated Colonic Afferent Activation But Not Psychological Scores in Patients With IBS-D

C. Lam, R. Spiller, J. Wood, 2021, Clinical and translational gastroenterology.

Abnormalities of mucosal serotonin metabolism and 5‐HT3 receptor subunit 3C polymorphism in irritable bowel syndrome with diarrhoea predict responsiveness to ondansetron

I. Hall, K. Garsed, C. Lam, 2019, Alimentary pharmacology & therapeutics.

712 A Multi-Centre, Parallel Group, Randomised Placebo Controlled Trial of Mesalazine for Treatment of Diarrhoea-Predominant Irritable Bowel Syndrome (IBS-D)

C. Lam, P. Whorwell, R. Spiller, 2014 .

Differential Effects of FODMAPs (Fermentable Oligo-, Di-, Mono-Saccharides and Polyols) on Small and Large Intestinal Contents in Healthy Subjects Shown by MRI

C. Lam, L. Marciani, R. Spiller, 2013, The American Journal of Gastroenterology.

Differential Effects of FODMAPs (Fermentable Oligo-, Di-, Mono-Saccharides and Polyols) on Small and Large Intestinal Contents in Healthy Subjects Shown by MRI

C. Lam, L. Marciani, R. Spiller, 2014, The American Journal of Gastroenterology.